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and possible early warning of BRBV transmission risk. 
However, whether any of these mammalian species are com-
petent amplifier hosts for BRBV remains to be determined.
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Table. PRNT70 results for mammals tested for Bourbon virus–neutralizing antibodies, Missouri, USA, 2012–2013* 
Common name Species name No. positive/no. tested Titer Proportion positive (95% CI) 
Domestic cat Felis catus 0/2 <10 0 (0–0.66) 
Domestic dog Canis lupus familiaris 2/13 10–>320 0.15 (0.04–0.42) 
Eastern cottontail Sylvilagus floridanus 2/9 >320 0.22 (0.06–0.55) 
Fox squirrel Sciurus niger 0/4 <10 0 (0.0–0.49) 
Horse Equus caballus 1/24 20 0.04 (0.007–0.20) 
Raccoon Procyon lotor 31/62 10–>320 0.50 (0.38–0.62) 
Virginia opossum Didelphis virginiana 0/28 <10 0 (0.0–0.12) 
White-tailed deer Odocoileus virginianus 12/14 10–>320 0.86 (0.60–0.96) 
*PRNT70, 70% plaque reduction neutralization titer. 
 
Lassa fever has not been reported in Côte d’Ivoire. We per-
formed a retrospective analysis of human serum samples 
collected in Côte d’Ivoire in the dry seasons (January–April) 
during 2015–2018. We identified a fatal human case of 
Lassa fever in the Bangolo District of western Côte d’Ivoire 
during 2015.
Lassa fever is endemic to western Africa. Nigeria, Guin-ea, Sierra Leone, and Liberia regularly have outbreaks 
of Lassa fever, mostly during the first few months of the 
year, corresponding to the dry season (January–May), when 
the Mastomys natalensis rodent reservoir of Lassa fever vi-
rus (LASV) has more contact with the human population 
in rural areas to access food. The epidemic zone of Lassa 
fever has recently been extended into Benin, and sporadic 
cases have been documented in Burkina Faso, Mali, Ghana, 
and Togo.
Côte d’Ivoire appears to be an exception; no Lassa fe-
ver cases have been reported in this country. A tourist from 
Germany traveling through Côte d’Ivoire, Burkina, and 
Ghana died from Lassa fever upon her return to Germany 
but it was not possible to determine in which country she 
contracted the disease (1). In 2013, LASV RNA was iden-
tified in M. natalensis rodents captured in northern Côte 
d’Ivoire, near Korhogo (2). Virus RNA corresponded to 
the same AV strain of LASV as that isolated from the tour-
ist, suggesting that she might have been infected in Côte 
d’Ivoire. Seroprevalence among forest workers in western 
Côte d’Ivoire also suggests that LASV might currently cir-
culate in this country (3).
We performed a retrospective analysis of 268 human 
serum samples received at the National Reference Center 
for Yellow Fever (Institut Pasteur de Côte d’Ivoire, Abi-
djan, Côte d’Ivoire) for diagnosis of arbovirus infection. 
We selected yellow fever–negative samples from the west-
ern region of Côte d’Ivoire (Biankouma, Danané, Duék-
oué, Guiglo, Man, Odienné, Touba, Toulépleu, and Zouan 
Hounien Districts), near the borders with Liberia and Guin-
ea collected during January–April 2015–2018.
We inactivated serum samples by using AVL buffer 
(QIAGEN, https://www.qiagen.com) and ethanol and iso-
lated RNA by using the QIAamp Viral RNA Extraction 
Kit (QIAGEN). We analyzed RNA by using a reverse tran-
scription PCR (RT-PCR) and pan–Old World arenavirus 
primers specific for the large RNA segment (OW RT-PCR).
We identified 1 positive serum sample (001/15) by OW 
RT-PCR; we then determined that this sample was LASV 
positive by using a LASV-specific RT-PCR specific for the 
glycoprotein complex (GPC) gene (Figure, panel A). We 
sequenced amplicons for the GPC and L genes and aligned 
partial sequences of this new strain, Bangolo-CIV-2015, 
with the corresponding regions of a set of representative 
published LASV strains (4).
We generated phylogenetic trees by using a general 
time reversible plus gamma plus proportion of invariable 
sites model and parallel maximum-likelihood with Phy-
ML Smart Model Selection (5). The GPC (MK978784) 
and large RNA (MK978785) fragments of the Bangolo-
CIV-2015 strain (Figure, panel B) were genetically similar 
to strain BA-366 isolated from an M. natalensis rodent cap-
tured in the Bantou District of central Guinea during 2003 
(6). On the basis of these phylogenetic trees, we concluded 
that Bangolo-CIV-2015 belongs to the IV clade, along with 
the highly pathogenic LASV strain Josiah, and diverges 
from the clade V AV strain of LASV (Figure, panel B) 
found in rodents and a patient from Germany (1,2).
The LASV-positive serum sample originated from a 
30-year-old man from the Bangolo District of Côte d’Ivoire 
who was admitted to Duékoué Hospital in January 2015 be-
cause of fever, asthenia, and gingivorrhagia. His health rap-
idly deteriorated after admission; he had hypotension and 
a consciousness disorder and died 4 days later. The sample 
was collected at the time of death. Further investigations 
by doctors at Institut Pasteur de Côte d’Ivoire were unable 
to obtain more information about this patient. Without the 
travel history of the patient during the 3 weeks preceding 
his hospital admission, we could not determine whether 
this case of Lassa fever was endemic or imported. Exported 
cases are common (7) because many workers travel to Côte 
d’Ivoire from Guinea and Sierra Leone.
Next-generation sequencing in an outbreak set-
ting, combined with phylogenetic analyses, has recently 
showed that many strains of LASV have been responsible 
for cases of Lassa fever in Nigeria, suggesting indepen-
dent transmission events from the reservoir, rather than 
the emergence of an epidemic strain (8). The case we re-
port remains isolated because no other suspected cases 
were reported during this period. None of the healthcare 
workers who had been in contact with the patient showed 
any signs of Lassa fever. An additional set of 35 human 
serum samples collected during October 2014–April 2015 
in the Biankouma, Duékoué, Guiglo, Issia, Man, Minig-
nan, Odienne, Soubre, and Tengrela Districts were LASV 
negative by RT-PCR.
In 2015, Kouadio et al. highlighted possible under-
reporting of Lassa fever cases in Côte d’Ivoire because 
of lack of diagnoses (2). We provide evidence of a fa-
tal case of human Lassa fever in the Bangolo District of 
western Côte d’Ivoire. Thus, measures should be taken 
to reinforce the diagnosis of Lassa fever and arenavirus 
surveillance in general in this country. Human serologic 
surveys should help in identifying the area of LASV cir-
culation in Côte d’Ivoire. RNA from novel arenaviruses 
has recently been identified in rodents captured in Côte 
d’Ivoire, but their pathogenic potential for humans re-
mains unknown (9).
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Figure. Analysis of LASV 
strains, Bangolo District, Côte 
d’Ivoire, 2015. A) RT-PCR 
analysis of human serum 
samples 132/16 and 001/15 by 
using OW and LASV RT-PCRs. 
Lane 1, negative control; lane 2, 
positive control; lane 3, 132/16; 
lane 4, 001/15. B) Phylogenetic 
analysis of LASV strains. Trees 
were inferred by using the 
PhyML Smart Model Selection 
(5) general time-reversible 
plus gamma plus proportion 
of invariable sites model with 
200 bootstrap replicates. 
Poorly supported branches 
with bootstrap values <0.50 are 
indicated by dotted lines. Lassa 
virus lineages are indicated by 
the Roman numerals on the 
right. The Bangolo-CIV-2015 
strain (solid box), which was 
isolated in this study, appears to 
be related to clade IV, and the 
AV strain (dotted box) is related 
to clade V. GPC, glycoprotein 
complex gene; L, large RNA 
segment; LASV, Lassa virus; 
OW, Old World; RT-PCR, 
reverse transcription PCR.
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We identified a case of fatal acute respiratory disease 
from household transmission of human adenovirus type 
55 (HAdV-55) in Anhui Province, China. Computed tomog-
raphy showed severe pneumonia. Comparative genomic 
analysis of HAdV-55 indicated the virus possibly originated 
in Shanxi Province, China. More attention should be paid to 
highly contagious HAdV-55.
Human adenoviruses are associated with mild and acute respiratory infections, depending on the vi-
rus type and host immunity. Human adenovirus type 55 
(HAdV-55) (1), formerly known as HAdV-11a (2), is a 
reemergent respiratory pathogen that has caused severe 
pneumonia outbreaks in military and civilian populations 
in Europe and Asia (2–7). However, household transmis-
sion of HAdV-55 is rarely reported. We report a case of 
household transmission of HAdV-55 involving 3 con-
firmed adult cases with 1 death. Epidemiologic, clinical, 
and laboratory investigations, along with whole-genome 
sequencing, elucidate the disease progression and the 
pathogen origin.
During April 1–May 5, 2012, 7 household members (5 
males and 2 females; 3 children and 4 adults) in Anhui Prov-
ince, China, sequentially experienced influenza-like symp-
toms, including fever, productive cough, fatigue, pharyngal-
gia, dyspnea, and other symptoms. The youngest patient was 
4 months of age, the oldest, whom we refer to as AQ-1, was 
a 55-year-old man. The family lived together near a farm in 
a house with poor sanitary and ventilation conditions. 
The first onset of acute respiratory disease (ARD) oc-
curred on April 1, when the index case, a 4-year-old grand-
daughter of AQ-1, had a febrile respiratory infection with 
cough. Three days later, AQ-1’s grandson, 1 year of age, 
displayed similar symptoms. On April 9 and 11, AQ-1’s 
daughter, 28 years of age, and another grandson, 4 months 
of age, both had influenza-like symptoms. On April 14, 
AQ-1 had a fever, chills, and lumbago. He was admitted to 
the hospital on April 14 where clinicians diagnosed pneu-
monia. AQ-1 had close contact with his sick grandsons and 
granddaughter and had not been out of the house during the 
month he cared for them. 
While hospitalized, AQ-1 had bilateral pneumonia 
seen on chest computed tomography (CT), a temperature of 
41.0°C, and low total leukocyte (3.63 × 109/L) and platelet 
(42 × 109/L) counts. AQ-1 sustained high fever and yellow 
phlegm despite antiinflammatory and antiviral treatment, 
including levofloxacin, piperacillin sodium, tazobactam so-
dium, and ribavirin. 
On April 24, AQ-1 had indications of severe pneumo-
nia, including respiratory failure, hypoxemia, double lung 
rales, and a mass of shadows visible on chest CT. In addi-
tion, he had indications of liver damage and multi-organ 
failure. Transverse chest CT images demonstrated in-
creased areas of patchy shadows and consolidation in both 
lungs compared to CT images from April 22, indicative of 
disease progression (Appendix Figure 1, http://wwwnc.
cdc.gov/EID/article/25/9/18-1937-App1.pdf).
AQ-1 died on April 27, 3 days after onset of respiratory 
failure, and 13 days after his illness began. On the same day, 
his 20-year-old son, AQ-2, and 31-year-old nephew, AQ-
3, who had taken care of AQ-1 for 5 days, also exhibited 
1756 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 25, No. 9, September 2019
RESEARCH LETTERS
1These authors contributed equally to this article.
